Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and adaptability

Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming administration will offer support.

Federal officials Wednesday released a far-reaching proposal to make cigarettes less addictive by capping their nicotine content.

The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application

U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first that could curb smoking and hit tobacco industry earnings. The U.S. Food and Drug Administration (FDA),

The proposed rule from the Food and Drug Administration comes in the final ... tobacco companies like Reynolds American and Altria are almost certain to challenge it in court, delaying implementation.

The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts.

T he U.S. Food and Drug Administration has banned the use of red dye No. 3 in foods, more than three decades after researchers discovered its link to cancer in rodents and to worsened attention deficit and hyperactivity disorder and other behavioral symptoms. The dye is already banned from foods in the European Union, New Zealand and Australia.

On Jan. 15, 2025, the U.S. Food and Drug Administration revoked its authorization for the use of Red Dye No. 3 in food and ingested medications.

Minnesota Attorney General Keith Ellison has filed a lawsuit against High Light Vapes, a Los Angeles-based e-cigarette manufacturer, charging it with marke

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. | The FDA has slapped a warning letter on Sanofi’s Genzyme facility in Framingham,

In its most recent effort to keep pace with advancing technology, the US Food and Drug Administration (FDA) recently issued two draft guidances on the use of artificial intelligence (AI) in the context of drugs,